Stay updated with breaking news from Huashan ruilian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
China Digest: GL Ventures backs Porton Biologics; Smartbi nets $15m funding Visual from Freedigitalphoto.net April 20, 2021 Suzhou Porton secured 400 million yuan ($62 million) from GL Ventures and others in a Series A round, while Smartbi has raised 100 million yuan ($15 million) in a Series B+ round of financing. GL Ventures invests in Porton Biologics Suzhou Porton Biologics Ltd., a subsidiary of Porton Pharma Solutions that focuses on gene and cell therapy services, has secured 400 million yuan ($62 million) in a Series A round. The financing attracted leading investors like state-backed CMC-SDIC Capital, Hillhouse Capital’s venture unit GL Ventures, HM Capital, Huashan Ruilian and Momentum Venture, according to a company statement on Tuesday. ....